The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes

NCT02081170 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Macular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or,
Large Size Macular Hole (Diameter > 600 Microns) or
Recurred or Failed Macular Hole From Previous Surgery
or Chronic Macular Hole (Symptom Duration > 6 Months)

Interventions

PROCEDURE: Autologous platelet concentrate

Sponsor

Samsung Medical Center